1	ASTRAZENECA	astrazeneca	NNP	_	11	nsubj	11:A0=PAG
2	,	,	,	_	1	punct	_
3	the	the	DT	_	8	det	_
4	UK	uk	NNP	_	6	hmod	_
5	-	-	HYPH	_	6	hyph	_
6	based	base	VBN	_	8	amod	_
7	pharmaceuticals	pharmaceutical	NNS	_	8	nn	_
8	giant	giant	NN	p2=JJ	1	appos	_
9	,	,	,	_	1	punct	_
10	has	have	VBZ	_	11	aux	_
11	rejected	reject	VBN	pb=reject.01	0	root	_
12	an	an	DT	_	16	det	_
13	improved	improve	VBN	p2=JJ|pb=improve.01	16	amod	_
14	£69bn	£0bn	JJ	p2=NN	16	amod	_
15	takeover	takeover	NN	_	16	nn	_
16	bid	bid	NN	_	11	dobj	11:A1=PPT;13:A1=PPT
17	from	from	IN	_	16	prep	_
18	America	america	NNP	_	20	poss	_
19	's	's	POS	_	18	possessive	_
20	Pfizer	pfizer	NNP	p2=NN	17	pobj	_
21	as	as	IN	p2=RB	20	prep	_
22	inadequate	inadequate	JJ	_	21	amod	_
23	.	.	.	_	11	punct	_

1	ASTRAZENECA	astrazeneca	NNP	_	11	nsubj	11:A0=PAG
2	,	,	,	_	1	punct	_
3	the	the	DT	_	8	det	_
4	UK	uk	NNP	_	6	hmod	_
5	-	-	HYPH	_	6	hyph	_
6	based	base	VBN	_	8	amod	_
7	pharmaceuticals	pharmaceutical	NNS	_	8	nn	_
8	giant	giant	NN	p2=JJ	1	appos	_
9	,	,	,	_	1	punct	_
10	has	have	VBZ	_	11	aux	_
11	rejected	reject	VBN	pb=reject.01	0	root	_
12	an	an	DT	_	16	det	_
13	improved	improve	VBN	p2=JJ|pb=improve.01	16	amod	_
14	£69bn	£0bn	JJ	p2=NN	16	amod	_
15	takeover	takeover	NN	_	16	nn	_
16	bid	bid	NN	_	11	dobj	11:A1=PPT;13:A1=PPT
17	from	from	IN	_	16	prep	_
18	America	america	NNP	_	20	poss	_
19	's	's	POS	_	18	possessive	_
20	Pfizer	pfizer	NNP	p2=NN	17	pobj	_
21	as	as	IN	p2=RB	20	prep	_
22	inadequate	inadequate	JJ	_	21	amod	_
23	.	.	.	_	11	punct	_

1	The	the	DT	_	2	det	_
2	decision	decision	NN	_	24	nsubjpass	24:A1=PPT
3	by	by	IN	_	2	prep	_
4	the	the	DT	_	5	det	_
5	board	board	NN	_	3	pobj	_
6	of	of	IN	_	5	prep	_
7	AstraZeneca	astrazeneca	NNP	_	6	pobj	_
8	to	to	TO	_	9	aux	_
9	oppose	oppose	VB	pb=oppose.01	2	infmod	_
10	what	what	WP	_	12	nsubj	12:R-A1
11	would	would	MD	_	12	aux	12:AM-MOD
12	be	be	VB	pb=be.01	9	ccomp	9:A1=PPT
13	the	the	DT	_	18	det	_
14	largest	large	JJS	p2=RBS	16	hmod	_
15	-	-	HYPH	p2=,	16	hyph	_
16	ever	ever	RB	_	18	amod	_
17	foreign	foreign	JJ	_	18	amod	_
18	acquisition	acquisition	NN	_	12	attr	12:A2=PRD
19	of	of	IN	_	18	prep	_
20	a	a	DT	_	22	det	_
21	British	british	JJ	_	22	amod	_
22	company	company	NN	_	19	pobj	_
23	was	be	VBD	_	24	auxpass	_
24	backed	back	VBN	pb=back.01	0	root	_
25	by	by	IN	_	24	agent	24:A0=PAG
26	Aberdeen	aberdeen	NNP	_	28	nn	_
27	Asset	asset	NNP	_	28	nn	_
28	Management	management	NNP	_	25	pobj	_
29	,	,	,	_	24	punct	_
30	which	which	WDT	_	31	nsubj	31:R-A0
31	said	say	VBD	pb=say.01	24	advcl	_
32	Pfizer	pfizer	NNP	p2=NN	35	nsubj	35:A0=PAG
33	could	could	MD	_	35	aux	35:AM-MOD
34	have	have	VB	_	35	aux	_
35	done	do	VBN	pb=do.02	31	ccomp	31:A1=PPT
36	better	well	RBR	_	35	advmod	35:AM-MNR
37	.	.	.	_	24	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nsubj	3:A0
2	has	have	VBZ	_	3	aux	_
3	said	say	VBN	p2=VBD|pb=say.01	0	root	_
4	the	the	DT	_	6	det	_
5	latest	late	JJS	_	6	amod	_
6	offer	offer	NN	p2=VBP	7	nsubj	7:A1=PPT
7	was	be	VBD	pb=be.01	3	ccomp	3:A1=PPT
8	final	final	JJ	_	7	acomp	7:A2=PRD
9	but	but	CC	_	7	cc	_
10	there	there	EX	_	11	expl	_
11	was	be	VBD	pb=be.02	7	conj	_
12	speculation	speculation	NN	_	11	attr	11:A1=PPT
13	yesterday	yesterday	NN	_	11	npadvmod	11:AM-TMP
14	it	it	PRP	_	16	nsubj	16:A1=PPT
15	may	may	MD	_	16	aux	16:AM-MOD
16	return	return	VB	pb=return.01	3	ccomp	_
17	to	to	IN	_	16	prep	16:A4=GOL
18	the	the	DT	_	19	det	_
19	fray	fray	NN	_	17	pobj	_
20	.	.	.	_	3	punct	_

1	With	with	IN	_	14	prep	14:AM-ADV
2	2.5	0	CD	_	4	num	_
3	per	per	NN	p2=IN	4	nn	_
4	cent	cent	NN	_	1	pobj	_
5	of	of	IN	_	4	prep	_
6	AstraZeneca	astrazeneca	NNP	_	8	poss	_
7	's	's	POS	_	6	possessive	_
8	shares	share	NNS	_	5	pobj	_
9	,	,	,	_	14	punct	_
10	Aberdeen	aberdeen	NNP	_	12	nn	_
11	Asset	asset	NNP	_	12	nn	_
12	Management	management	NNP	p2=NN	14	nsubj	14:A0=PAG
13	could	could	MD	_	14	aux	14:AM-MOD
14	have	have	VB	pb=have.03	0	root	_
15	a	a	DT	_	17	det	_
16	significant	significant	JJ	_	17	amod	_
17	influence	influence	NN	_	14	dobj	14:A1=PPT
18	on	on	IN	_	17	prep	_
19	events	event	NNS	_	18	pobj	_
20	.	.	.	_	14	punct	_

1	The	the	DT	_	3	det	_
2	asset	asset	NN	_	3	nn	_
3	manager	manager	NN	_	7	poss	_
4	's	's	POS	_	3	possessive	_
5	chief	chief	JJ	_	7	amod	_
6	investment	investment	NN	_	7	nn	_
7	officer	officer	NN	_	10	nsubj	10:A0
8	Anne	anne	NNP	_	9	nn	_
9	Richards	richards	NNP	_	7	appos	_
10	said	say	VBD	pb=say.01	0	root	_
11	the	the	DT	_	13	det	_
12	latest	late	JJS	_	13	amod	_
13	£55	£0	NN	p2=CD	16	nn	_
14	per	per	IN	p2=PRP$	13	prep	_
15	share	share	NN	_	14	pobj	_
16	offer	offer	NN	p2=VBP	19	nsubj	19:A1=PPT
17	from	from	IN	_	16	prep	_
18	Pfizer	pfizer	NNP	_	17	pobj	_
19	was	be	VBD	pb=be.01	10	ccomp	10:A1=PPT
20	better	good	JJR	_	19	acomp	19:A2=PRD
21	than	than	IN	_	20	prep	_
22	the	the	DT	_	24	det	_
23	£53.50	£0	NN	p2=CD	24	nn	_
24	approach	approach	NN	p2=VBP	21	pobj	26:A1=PPT
25	AstraZeneca	astrazeneca	NNP	_	26	nsubj	26:A0=PAG
26	spurned	spurn	VBD	pb=spurn.01	24	rcmod	_
27	last	last	JJ	_	28	amod	_
28	week	week	NN	_	26	npadvmod	26:AM-TMP
29	but	but	CC	_	10	cc	_
30	certainly	certainly	RB	_	31	advmod	31:AM-ADV
31	was	be	VBD	p2=VBZ|pb=be.01	10	conj	_
32	n't	not	RB	_	31	neg	31:AM-NEG
33	a	a	DT	_	34	det	_
34	knock	knock	VB	p2=NN	31	nsubj	31:A1=PPT
35	out	out	RP	_	34	prt	_
36	.	.	.	_	10	punct	_

1	"	"	``	p2=''	16	punct	_
2	Valuing	value	VBG	p2=NNP|pb=value.01	12	csubj	12:A1=PPT
3	the	the	DT	_	4	det	_
4	pipeline	pipeline	NN	_	2	dobj	2:A1
5	of	of	IN	_	4	prep	_
6	future	future	JJ	p2=NN	7	amod	_
7	products	product	NNS	_	5	pobj	_
8	in	in	IN	_	4	prep	_
9	a	a	DT	_	11	det	_
10	pharmaceutical	pharmaceutical	JJ	p2=NN	11	amod	_
11	company	company	NN	_	8	pobj	_
12	is	be	VBZ	pb=be.01	16	ccomp	16:A1=PPT
13	notoriously	notoriously	RB	_	14	advmod	_
14	tricky	tricky	JJ	_	12	acomp	12:A2=PRD
15	"	"	''	p2=``	16	punct	_
16	said	say	VBD	pb=say.01	0	root	_
17	Ms	ms	NNP	p2=NNPS	18	nn	_
18	Richards	richards	NNP	_	16	nsubj	16:A0;20:A0=PAG
19	,	,	,	_	16	punct	_
20	adding	add	VBG	pb=add.01	16	advcl	16:AM-ADV
21	:	:	:	_	20	punct	_
22	"	"	``	_	20	punct	_
23	Takeovers	takeover	NNS	p2=NNPS	29	nsubj	29:A1=PPT
24	in	in	IN	_	23	prep	_
25	the	the	DT	_	27	det	_
26	pharmaceutical	pharmaceutical	JJ	p2=NN	27	amod	_
27	sector	sector	NN	_	24	pobj	_
28	can	can	MD	_	29	aux	29:AM-MOD
29	be	be	VB	pb=be.01	20	ccomp	20:A1=PPT
30	disruptive	disruptive	JJ	_	29	acomp	29:A2=PRD
31	to	to	IN	p2=TO	30	prep	_
32	research	research	NN	_	31	pobj	_
33	and	and	CC	_	32	cc	_
34	development	development	NN	_	32	conj	_
35	and	and	CC	_	29	cc	_
36	do	do	VBP	p2=VB	39	aux	_
37	n't	not	RB	_	39	neg	39:AM-NEG
38	always	always	RB	_	39	advmod	39:AM-TMP
39	increase	increase	VB	pb=increase.01	29	conj	_
40	shareholder	shareholder	NN	_	41	nn	_
41	value	value	NN	_	39	dobj	39:A1=PPT
42	.	.	.	_	16	punct	_
43	"	"	''	_	16	punct	_

1	She	she	PRP	_	2	nsubj	2:A0=PAG
2	noted	note	VBD	pb=note.01	0	root	_
3	shareholders	shareholder	NNS	_	6	nsubjpass	6:A2=GOL
4	would	would	MD	_	6	aux	6:AM-MOD
5	be	be	VB	_	6	auxpass	_
6	paid	pay	VBN	pb=pay.01	2	ccomp	2:A1=PPT
7	more	more	JJR	_	9	amod	_
8	than	than	IN	_	9	quantmod	_
9	half	half	PDT	_	12	num	_
10	the	the	DT	_	12	det	_
11	takeover	takeover	NN	_	12	nn	_
12	price	price	NN	_	6	dobj	6:A1=VSP
13	in	in	IN	_	6	prep	6:AM-LOC
14	Pfizer	pfizer	NNP	p2=NN	15	nn	_
15	shares	share	NNS	p2=NNP	13	pobj	_
16	,	,	,	_	6	punct	_
17	listed	list	VBN	pb=list.01	6	advcl	6:AM-ADV
18	in	in	IN	_	17	prep	17:A2=GOL
19	the	the	DT	_	20	det	_
20	US	us	NNP	_	18	pobj	_
21	.	.	.	_	2	punct	_

1	AstraZeneca	astrazeneca	NNP	p2=NN	2	nn	_
2	chairman	chairman	NN	_	4	nn	_
3	Leif	leif	NNP	_	4	nn	_
4	Johansson	johansson	NNP	_	5	nsubj	5:A0
5	said	say	VBD	pb=say.01	0	root	_
6	he	he	PRP	_	8	nsubj	8:A0=PAG
7	had	have	VBD	_	8	aux	_
8	told	tell	VBN	p2=VBD|pb=tell.01	5	ccomp	5:A1=PPT
9	Pfizer	pfizer	NNP	_	8	dobj	8:A2=GOL
10	in	in	IN	_	8	prep	8:AM-LOC
11	discussions	discussion	NNS	_	10	pobj	_
12	that	that	IN	p2=WDT	17	complm	_
13	his	his	PRP$	_	14	poss	_
14	board	board	NN	_	17	nsubj	17:A0=PAG
15	could	could	MD	_	17	aux	17:AM-MOD
16	only	only	RB	_	17	advmod	17:AM-ADV
17	recommend	recommend	VB	pb=recommend.01	8	ccomp	8:A1=PPT
18	a	a	DT	_	19	det	_
19	bid	bid	NN	_	17	dobj	17:A1=PPT;21:A1=PPT
20	that	that	WDT	p2=DT	21	nsubj	21:R-A1
21	was	be	VBD	pb=be.01	19	rcmod	_
22	at	at	IN	p2=RB	23	advmod	_
23	least	least	JJS	p2=RBS	24	advmod	_
24	10	0	CD	_	26	num	_
25	per	per	NN	p2=IN	26	nn	_
26	cent	cent	NN	_	27	npadvmod	_
27	above	above	IN	p2=RB	21	prep	21:A2=PRD
28	an	an	DT	_	29	det	_
29	offer	offer	NN	_	27	pobj	_
30	of	of	IN	_	29	prep	_
31	£53.50	£0	NN	p2=CD	32	amod	_
32	pounds	pound	NNS	_	30	pobj	33:A1
33	made	make	VBN	pb=make.LV	32	partmod	_
34	by	by	IN	_	33	agent	33:A0
35	Pfizer	pfizer	NNP	_	34	pobj	_
36	on	on	IN	_	33	prep	33:AM-TMP
37	Friday	friday	NNP	_	36	pobj	_
38	,	,	,	_	37	punct	_
39	or	or	CC	_	37	cc	_
40	£58.85	£0	CD	p2=NN	37	conj	_
41	.	.	.	_	5	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nsubj	2:A0=PAG;4:A0=PAG
2	wants	want	VBZ	pb=want.01	0	root	_
3	to	to	TO	_	4	aux	_
4	create	create	VB	pb=create.01	2	xcomp	2:A1=PPT
5	the	the	DT	_	6	det	_
6	world	world	NN	_	10	poss	_
7	's	's	POS	_	6	possessive	_
8	largest	large	JJS	_	10	amod	_
9	drugs	drug	NNS	_	10	nn	_
10	firm	firm	NN	p2=JJ	4	dobj	4:A1=PPT
11	,	,	,	_	4	punct	_
12	with	with	IN	_	4	prep	_
13	a	a	DT	_	14	det	_
14	headquarters	headquarters	NN	_	12	pobj	_
15	in	in	IN	_	14	prep	_
16	New	new	NNP	_	17	nn	_
17	York	york	NNP	_	15	pobj	_
18	but	but	CC	p2=IN	14	cc	_
19	a	a	DT	_	21	det	_
20	tax	tax	NN	_	21	nn	_
21	base	base	NN	_	14	conj	_
22	in	in	IN	_	21	prep	_
23	Britain	britain	NNP	_	22	pobj	29:AM-LOC
24	,	,	,	_	23	punct	_
25	where	where	WRB	_	29	advmod	29:R-AM-LOC
26	corporation	corporation	NN	_	28	nn	_
27	tax	tax	NN	_	28	nn	_
28	rates	rate	NNS	_	29	nsubj	29:A1=PPT
29	are	be	VBP	pb=be.01	23	rcmod	_
30	lower	low	JJR	_	29	acomp	29:A2=PRD
31	than	than	IN	_	30	prep	_
32	in	in	IN	_	31	prep	_
33	the	the	DT	_	35	det	_
34	United	united	NNP	_	35	nn	_
35	States	states	NNP	_	32	pobj	_
36	.	.	.	_	2	punct	_

1	The	the	DT	_	2	det	_
2	plan	plan	NN	_	4	nsubj	4:A0=PAG
3	has	have	VBZ	_	4	aux	_
4	met	meet	VBN	pb=meet.01	0	root	_
5	entrenched	entrenched	JJ	p2=VBN	6	amod	_
6	opposition	opposition	NN	_	4	dobj	4:A1=PPT
7	from	from	IN	_	6	prep	_
8	AstraZeneca	astrazeneca	NNP	_	7	pobj	_
9	,	,	,	_	6	punct	_
10	as	as	RB	_	12	advmod	_
11	well	well	RB	_	12	advmod	_
12	as	as	IN	_	6	cc	_
13	politicians	politician	NNS	_	6	conj	_
14	and	and	CC	_	13	cc	_
15	scientists	scientist	NNS	_	13	conj	17:A0=PPT
16	who	who	WP	p2=VBP	17	nsubj	17:R-A0
17	fear	fear	VBP	pb=fear.01	15	rcmod	_
18	cuts	cut	NNS	_	17	dobj	17:A1=PAG
19	to	to	IN	_	17	prep	_
20	jobs	job	NNS	_	19	pobj	_
21	and	and	CC	_	20	cc	_
22	research	research	NN	_	20	conj	_
23	.	.	.	_	4	punct	_

1	Mr	mr	NNP	_	2	nn	_
2	Johansson	johansson	NNP	_	3	nsubj	3:A0
3	said	say	VBD	pb=say.01	0	root	_
4	Pfizer	pfizer	NNP	_	6	poss	_
5	's	's	POS	_	4	possessive	_
6	approach	approach	NN	_	9	nsubjpass	9:A1=PPT
7	had	have	VBD	_	9	aux	_
8	been	be	VBN	_	9	auxpass	_
9	driven	drive	VBN	pb=drive.02	3	ccomp	3:A1=PPT
10	by	by	IN	_	9	agent	9:A0=PAG
11	the	the	DT	_	14	det	_
12	corporate	corporate	JJ	_	14	amod	_
13	financial	financial	JJ	_	14	amod	_
14	benefits	benefit	NNS	_	10	pobj	_
15	to	to	IN	_	14	prep	_
16	its	its	PRP$	_	17	poss	_
17	shareholders	shareholder	NNS	_	15	pobj	_
18	of	of	IN	_	17	prep	_
19	cost	cost	NN	p2=JJ	20	nn	_
20	savings	saving	NNS	_	18	pobj	_
21	and	and	CC	_	20	cc	_
22	tax	tax	NN	_	23	nn	_
23	minimisation	minimisation	NN	_	20	conj	_
24	.	.	.	_	3	punct	_

1	Aberdeen	aberdeen	NNP	_	3	nn	_
2	Asset	asset	NNP	_	3	nn	_
3	Management	management	NNP	_	6	poss	_
4	's	's	POS	_	3	possessive	_
5	chief	chief	JJ	_	6	amod	_
6	executive	executive	NN	_	9	nsubj	9:A0
7	Martin	martin	NNP	_	8	nn	_
8	Gilbert	gilbert	NNP	_	6	appos	_
9	said	say	VBD	pb=say.01	0	root	_
10	recently	recently	RB	_	9	advmod	9:AM-TMP
11	the	the	DT	_	13	det	_
12	proposed	propose	VBN	p2=JJ|pb=propose.01	13	amod	_
13	deal	deal	NN	p2=VBP	14	nsubj	14:A0=PAG;12:A1=PPT
14	raised	raise	VBD	p2=VBN|pb=raise.01	9	ccomp	9:A1=PPT
15	public	public	JJ	_	16	amod	_
16	interest	interest	NN	_	17	nn	_
17	issues	issue	NNS	_	14	dobj	14:A1=PPT
18	.	.	.	_	9	punct	_

1	But	but	CC	_	6	cc	6:AM-DIS
2	,	,	,	_	6	punct	_
3	some	some	DT	_	5	det	_
4	big	big	JJ	_	5	amod	_
5	shareholders	shareholder	NNS	_	6	nsubj	6:A1=PPT
6	appeared	appear	VBD	pb=appear.01	0	root	_
7	unhappy	unhappy	JJ	_	6	oprd	6:C-A1
8	yesterday	yesterday	NN	_	6	npadvmod	6:AM-TMP
9	,	,	,	_	6	punct	_
10	when	when	WRB	_	15	advmod	15:R-AM-TMP
11	Astrazeneca	astrazeneca	NNP	_	14	poss	_
12	's	's	POS	_	11	possessive	_
13	share	share	NN	p2=VBP	14	nn	_
14	price	price	NN	_	15	nsubj	15:A1=PPT
15	fell	fall	VBD	pb=fall.01	6	advcl	6:AM-TMP
16	11	0	CD	_	18	num	_
17	per	per	NN	p2=IN	18	nn	_
18	cent	cent	NN	_	15	npadvmod	15:A2=EXT
19	,	,	,	_	15	punct	_
20	£5.36p	£0p	''	p2=,	15	punct	_
21	to	to	IN	p2=TO	15	prep	15:A4=GOL
22	£42.88	£0	CD	p2=NN	21	pobj	_
23	.	.	.	_	6	punct	_

1	Alastair	alastair	NNP	p2=JJ	2	nn	_
2	Gunn	gunn	NNP	_	7	nsubj	7:A0
3	of	of	IN	_	2	prep	_
4	Jupiter	jupiter	NNP	_	5	nn	_
5	Fund	fund	NNP	_	6	nn	_
6	Management	management	NNP	_	3	pobj	_
7	said	say	VBD	pb=say.01	0	root	_
8	:	:	:	_	7	punct	_
9	"	"	``	_	7	punct	_
10	We	we	PRP	_	11	nsubj	11:A1=PPT;12:A1=PPT
11	are	be	VBP	pb=be.01	18	ccomp	_
12	disappointed	disappoint	VBN	p2=VBG|pb=disappoint.01	11	acomp	11:A2=PRD
13	the	the	DT	_	14	det	_
14	board	board	NN	_	18	nsubj	18:A0=PAG
15	of	of	IN	_	14	prep	_
16	AstraZeneca	astrazeneca	NNP	_	15	pobj	_
17	has	have	VBZ	_	18	aux	_
18	rejected	reject	VBN	pb=reject.01	7	ccomp	7:A1=PPT
19	Pfizer	pfizer	NNP	p2=NN	22	poss	_
20	's	's	POS	_	19	possessive	_
21	latest	late	JJS	_	22	amod	_
22	offer	offer	NN	p2=VBP	18	dobj	18:A1=PPT
23	so	so	RB	_	24	advmod	_
24	categorically	categorically	RB	_	18	advmod	18:AM-TMP
25	.	.	.	_	7	punct	_

1	They	they	PRP	_	3	nsubj	3:A0=PAG;6:A0=PAG
2	should	should	MD	_	3	aux	3:AM-MOD
3	have	have	VB	pb=have.03	0	root	_
4	at	at	RB	p2=IN	5	advmod	_
5	least	least	RBS	_	6	advmod	6:AM-ADV
6	engaged	engage	VBN	p2=JJ|pb=engage.01	3	xcomp	_
7	in	in	IN	_	6	prep	6:A2=PPT
8	a	a	DT	_	10	det	_
9	constructive	constructive	JJ	_	10	amod	_
10	conversation	conversation	NN	_	7	pobj	_
11	with	with	IN	_	10	prep	_
12	Pfizer	pfizer	NNP	p2=NN	11	pobj	_
13	.	.	.	_	3	punct	_
14	"	"	''	_	3	punct	_

1	The	the	DT	_	2	det	_
2	firm	firm	NN	_	3	nsubj	3:A0=PAG
3	has	have	VBZ	pb=have.03	0	root	_
4	until	until	IN	_	3	prep	3:AM-TMP
5	May	may	NNP	_	4	pobj	_
6	26	0	CD	_	5	num	_
7	to	to	TO	_	8	aux	_
8	increase	increase	VB	pb=increase.01	0	root	_
9	its	its	PRP$	_	10	poss	_
10	offer	offer	NN	_	8	dobj	8:A1=PPT
11	under	under	IN	_	10	prep	_
12	UK	uk	NNP	_	14	nn	_
13	takeover	takeover	NN	_	14	nn	_
14	rules	rule	NNS	_	11	pobj	_
15	.	.	.	_	3	punct	_

1	Mr	mr	NNP	_	2	nn	_
2	Johanssen	johanssen	NNP	_	3	nsubj	3:A0
3	said	say	VBD	pb=say.01	0	root	_
4	:	:	:	_	3	punct	_
5	"	"	``	_	3	punct	_
6	I	I	PRP	_	7	nsubj	7:A0
7	think	think	VBP	pb=think.01	3	ccomp	3:A1=PPT
8	the	the	DT	_	9	det	_
9	language	language	NN	_	10	nsubj	10:A1=PPT
10	is	be	VBZ	pb=be.01	7	ccomp	7:A1=PPT
11	very	very	RB	_	12	advmod	_
12	clear	clear	JJ	_	10	acomp	10:A2=PRD
13	in	in	IN	_	10	prep	10:AM-LOC
14	Pfizer	pfizer	NNP	_	16	poss	_
15	's	's	POS	_	14	possessive	_
16	letter	letter	NN	_	13	pobj	_
17	that	that	IN	_	19	complm	_
18	this	this	DT	_	19	nsubj	19:A1=PPT
19	is	be	VBZ	pb=be.01	16	ccomp	_
20	their	their	PRP$	_	26	poss	_
21	absolute	absolute	JJ	_	26	amod	_
22	last	last	JJ	_	26	amod	_
23	and	and	CC	_	22	cc	_
24	final	final	JJ	_	22	conj	_
25	(	(	-LRB-	_	26	punct	_
26	offer	offer	NN	p2=VBP	19	attr	19:A2=PRD
27	)	)	-RRB-	_	19	punct	_
28	.	.	.	_	3	punct	_

1	I	I	PRP	_	2	nsubj	2:A0
2	think	think	VBP	pb=think.01	0	root	_
3	the	the	DT	_	8	det	_
4	(	(	-LRB-	_	8	punct	_
5	UK	uk	NNP	_	8	nn	_
6	)	)	-RRB-	_	8	punct	_
7	Takeover	takeover	NNP	p2=NN	8	nn	_
8	Panel	panel	NNP	_	10	nsubj	10:A0=PAG
9	might	might	MD	_	10	aux	10:AM-MOD
10	hold	hold	VB	pb=hold.01	2	ccomp	2:A1=PPT
11	them	them	PRP	_	10	dobj	10:A1=PPT
12	to	to	IN	_	10	prep	10:A2=GOL
13	that	that	DT	_	12	pobj	_
14	.	.	.	_	2	punct	_
15	"	"	''	_	2	punct	_

1	Ms	ms	NNP	p2=NNPS	2	nn	_
2	Richards	richards	NNP	_	3	nsubj	3:A0
3	said	say	VBD	pb=say.01	0	root	_
4	:	:	:	_	3	punct	_
5	"	"	``	_	3	punct	_
6	We	we	PRP	_	9	nsubj	9:A1=PPT
7	would	would	MD	_	9	aux	9:AM-MOD
8	n't	not	RB	_	9	neg	9:AM-NEG
9	be	be	VB	pb=be.01	3	ccomp	3:A1=PPT
10	surprised	surprised	JJ	_	9	acomp	9:A2=PRD
11	if	if	IN	_	16	mark	_
12	they	they	PRP	_	16	nsubj	16:A1=PPT
13	(	(	-LRB-	_	12	punct	_
14	Pfizer	pfizer	NNP	_	12	appos	_
15	)	)	-RRB-	_	12	punct	_
16	came	come	VBD	pb=come.01	9	advcl	9:AM-ADV
17	back	back	RB	p2=RP	16	advmod	16:AM-DIR
18	at	at	IN	_	17	prep	_
19	some	some	DT	_	20	det	_
20	point	point	NN	_	18	pobj	_
21	.	.	.	_	3	punct	_
22	"	"	''	_	3	punct	_

1	We	we	PRP	_	2	nsubj	2:A0=PAG
2	moderate	moderate	VBP	p2=JJ|pb=moderate.01	0	root	_
3	all	all	DT	p2=RB	4	det	_
4	comments	comment	NNS	_	2	dobj	2:A1=PPT
5	on	on	IN	_	4	prep	_
6	HeraldScotland	heraldscotland	NNP	_	5	pobj	_
7	on	on	IN	_	4	prep	_
8	either	either	CC	_	13	preconj	_
9	a	a	DT	_	13	det	_
10	pre-moderated	pre-moderated	JJ	_	13	amod	_
11	or	or	CC	_	10	cc	_
12	post-moderated	post-moderated	JJ	_	10	conj	_
13	basis	basis	NN	_	7	pobj	_
14	.	.	.	_	2	punct	_

